Interagency Patent Coordination and Improvement Act of 2025

This bill would create a joint task force between the U.S. Patent and Trademark Office and the Food and Drug Administration. The task force’s purpose is to share information and provide technical help on patent matters, so the two agencies can coordinate better on patent issues.

Key points:

• Who is affected: The U.S. Patent and Trademark Office and the Food and Drug Administration.
• What changes: A new interagency task force is set up to share information and offer technical assistance about patents.
• When: The provided text does not include timing details.